Pharma-Bio Serv (PBSV) Short term Debt (2020 - 2021)
Pharma-Bio Serv's (PBSV) quarterly Short term Debt came in at $1.3 million in Q2 2021, up 100.0% on a YoY basis from $643900.0 in Q2 2020, and little changed quarter-over-quarter from $1.3 million in Q1 2021.
Powered by 
Analysis
Pharma-Bio Serv (PBSV) Short term Debt (2020 - 2021) Analysis & Trends
Pharma-Bio Serv (PBSV) has reported Short term Debt for 2 consecutive years, with $1.3 million the latest figure, recorded in Q2 2021.
- For the quarter ending Q2 2021, Short term Debt rose 100.0% year-over-year to $1.3 million; the trailing twelve-month figure through Apr 2021 stood at $1.3 million (up 100.0% YoY), and the FY2020 full-year result was $1.3 million, changed N/A from the prior year.
- Short term Debt was little changed at $1.3 million in Q2 2021 per PBSV's latest filing, from $1.3 million in the prior quarter.
- Across five years, Short term Debt topped out at $1.3 million in Q4 2020 and bottomed at $643900.0 in Q2 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Accenture | 124.62 Bn | 115.58 Bn | 6.13 Bn |
| 2 | UL Solutions | 14.92 Bn | 14.51 Bn | 417.00 Mn |
| 3 | Gartner | 11.76 Bn | 10.28 Bn | 1.19 Bn |
| 4 | Tetra Tech | 9.19 Bn | 8.96 Bn | 243.21 Mn |
| 5 | Booz Allen Hamilton Holding | 8.76 Bn | 8.22 Bn | 1.46 Bn |
| 6 | Genpact | 6.27 Bn | 5.75 Bn | 490.34 Mn |
| 7 | Korn Ferry | 4.28 Bn | 3.15 Bn | 685.99 Mn |
| 8 | Fti Consulting | 4.20 Bn | 4.04 Bn | 316.27 Mn |
| 9 | Grand Canyon Education | 4.01 Bn | 3.73 Bn | 204.08 Mn |
| 10 | Pharma-Bio Serv | 12.37 Mn | 3.89 Mn | 902,041.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2021 | 1.29 Mn |
| Jan 31, 2021 | 1.29 Mn |
| Oct 31, 2020 | 1.29 Mn |
| Jul 31, 2020 | 965,850.00 |
| Apr 30, 2020 | 643,900.00 |